CoChat

The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat

Open access
Liang, Shuai, Deng, Xin, Lei, Lei, Zheng, Yao, Ai, Jiao, Chen, Linlin, Xiong, Hui, Mei, Zhinan, Cheng, Yung-Chi, Ren, Yongshen · 2019 · Frontiers in Pharmacology
Cited by 95

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Baicalin and baicalein are the primary effective substance of scutellaria baicalensis. It has been reported that baicalin and baicalein protect rats from ulcerative colitis(UC). Baicalin and baicalein have differential pharmacological of activities anti-inflammation, anti-oxidation, lipid-lowering and liver-protection in vivo and in vitro. It has been reported that UC has a great relationship with TH17/Treg regulation. The current study’s aims to determine the pharmacodynamic differences and potential mechanisms of baicalin, baicalein and their combinations[YSR(Young scutellaria baicalensis ratio of baicalin and baicalein=4:1), WSR(Withered scutellaria baicalensis ratio of baicalin and baicalein=1:1)] in the treatment of UC. We established UC model rats by composite factors [high-sugar and high-fat diet, high-temperature and high-humidity environment(HTHE) with Escherichia coli infection] to compare the therapeutic Effects and mechanisms of baicalin, baicalein and their combination, and then analyzed their metabolism in target tissue. As a result, the study shows that baicalin, baicalein, YSR, and WSR all have significantly therapeutic effects on UC, and have significantly different in the treatment of UC in the clinical symptoms and signs, such as fever, organ/body weight(BW) ratio, serum inflammatory cytokines levels, blood biochemistry and histopathology changes of main organs. We found that baicalin and baicalein have more potency in treating UC, and their combination provides a more comprehensive treatment, along with the higher of baicalin proportion, YSR generated the best effective treatment, which conforms to the traditional concept of optimization young Scutellaria baicalensis(Tiaoqin in Chinese) in treating large intestine disease. LC-MS/MS results show the conversion of baicalin and baicalein(in separation or combination) into six metabolites, baicalin, wogonoside, melaloside A, baicalein, Wogonin, and lamellar A e.g.. The levels of the six metabolites were significantly different in the large intestine, small intestine, and lung, but not in the serum. These results indicate that baicalin and baicalein should be used more accurately in specific diseases, especially baicalin or high content of baicalin in Scutellaria baicalensis should be preferred in treatment of UC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2019.01466

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 95

Metadata

Authors
Liang, S., Deng, X., Lei, L., Zheng, Y., Ai, J., Chen, L., Xiong, H., Mei, Z., Cheng, Y.-C., & Ren, Y.
Venue
Frontiers in Pharmacology
Published
2019-12-13
Volume
10
Pages
1466-1466
ISSN
1663-9812 (ISSN-L)
OpenAlex
W3008659397
Cited by
95
References
3
FWCI
6.01
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.